Edouard-Jules Laforgue

ggfggfff t
43
Documents

Publications

Publications

Image document

SONOPS Multicentre Cross-Sectional Study

Mélanie Duval , Maud Rodney , Morgane Rousselet , Choosie Jaquin , Elsa Garot et al.
International Dental Journal, 2025, ⟨10.1016/j.identj.2025.02.007⟩
Article dans une revue hal-04955700 v1
Image document

“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose

Aurélie Aquizerate , Morgane Rousselet , Axel Cochard , Marylène Guerlais , Marie Gerardin et al.
Harm Reduction Journal, 2024, 21 (1), pp.20. ⟨10.1186/s12954-024-00941-y⟩
Article dans une revue hal-04765025 v1

ESCAPE study: Cannabidiol use in patients treated for substance use disorders, prevalence of use and characteristics of users.

Mélanie Duval , Marion Istvan , Morgane Rousselet , Edouard-Jules Laforgue , Marie Grall-Bronnec et al.
European Addiction Research, 2024, pp.1-20. ⟨10.1159/000541887⟩
Article dans une revue hal-04824065 v1
Image document

A revisited version of the disputatio for pharmacological training: An educational study

Louise Carton , Perle Totoson , Edouard-Jules Laforgue , Jean-Marc Pelerin , Thomas Portier-Feunteun et al.
Therapies, 2024, 79 (4), pp.435-441. ⟨10.1016/j.therap.2023.10.016⟩
Article dans une revue hal-04805817 v1

Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study

Mélanie Pinhal , Benoît Schreck , Juliette Leboucher , Julie Abesdris , Malcolm Barrangou-Pouyes-Darlas et al.
Addiction Science and Clinical Practice, 2024, 19, pp.74. ⟨10.1186/s13722-024-00506-1⟩
Article dans une revue hal-04994166 v1
Image document

ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder—the influence of impulsivity as a mediating factor

Auxane Beslot , Marie Grall-Bronnec , Marianne Balem , Benoit Schreck , Edouard-Jules Laforgue et al.
Harm Reduction Journal, 2024, 21 (1), pp.165. ⟨10.1186/s12954-024-01079-7⟩
Article dans une revue hal-04717296 v1

Thromboembolic complications following recreational use of nitrous oxide: A French Addictovigilance alert

Caroline Victorri-Vigneau , Marylène Guerlais , Emmanuelle Jaulin , Edouard-Jules Laforgue , Marc-Antoine Pistorius
Thrombosis Research, 2024, 241, pp.109096. ⟨10.1016/j.thromres.2024.109096⟩
Article dans une revue hal-04785734 v1

Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database

Julien Li , Yoann Zelmat , Wilhelm Storck , Edouard Laforgue , Antoine Yrondi et al.
Journal of Affective Disorders, 2024, 350, pp.452-467. ⟨10.1016/j.jad.2024.01.119⟩
Article dans une revue hal-04789390 v1

Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report

Emilie Lefebvre , Luc Simons , Mélanie Duval , Edouard Laforgue , Caroline Victorri-Vigneau
Journal of Addiction Medicine, 2024, ⟨10.1097/ADM.0000000000001378⟩
Article dans une revue hal-04792448 v1
Image document

Physicians, pharmacists and take-home naloxone: What practices? The SINFONI study

Mélanie Duval , Aurélie Aquizerate , Emmanuelle Jaulin , Morgane Rousselet , Emmanuelle Kuhn et al.
Article dans une revue hal-04765493 v1

Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database

Marion Istvan , Mélanie Duval , Karl Hodel , Aurélie Aquizerate , Anicet Chaslerie et al.
European Archives of Psychiatry and Clinical Neuroscience, 2024, ⟨10.1007/s00406-024-01774-3⟩
Article dans une revue hal-04792516 v1

New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session

Benoît Schreck , Marion Istvan , Marylène Guerlais , Edouard-Jules Laforgue , Marie Gérardin et al.
Current Drug Metabolism, 2023, 24 (2), pp.80-91. ⟨10.2174/1389200224666230228103922⟩
Article dans une revue istex hal-04795180 v1
Image document

Nitrous oxide: a unique official French addictovigilance national survey

Marylène Guerlais , Aurélie Aquizerate , Arthur Lionnet , Amélie Daveluy , Mélanie Duval et al.
Frontiers in Public Health, 2023, 11, pp.1167746. ⟨10.3389/fpubh.2023.1167746⟩
Article dans une revue hal-04765021 v1
Image document

Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data

Edouard-Jules Laforgue , Marion Istvan , Anicet Chaslerie , Pascal Artarit , Geneviève Vallot et al.
Epidemiology and Psychiatric Sciences, 2023, 32, pp.e59. ⟨10.1017/S2045796023000732⟩
Article dans une revue inserm-04215734 v1
Image document

Evolution of the Addictovigilance Signal of Zopiclone: A 2014–2020 National Follow-up Study

Aurélie Aquizerate , Edouard-Jules Laforgue , Marion Istvan , Morgane Rousselet , Marie Gérardin et al.
International Journal of Mental Health and Addiction, 2023, ⟨10.1007/s11469-023-01078-y⟩
Article dans une revue hal-04795227 v1
Image document

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change

Aurélie Aquizerate , Edouard-Jules Laforgue , Marion Istvan , Morgane Rousselet , Marie Gerardin et al.
European Journal of Public Health, 2023, 33 (2), pp.169-175. ⟨10.1093/eurpub/ckad003⟩
Article dans une revue hal-04765007 v1

Nitrous oxide in France: Evolution of complications reported to the French monitoring system in the context of information from health authorities and regulatory measures

Marylène Guerlais , Aurélie Aquizerate , Amélie Daveluy , Arthur Lionnet , Marie Gerardin et al.
International Journal of Drug Policy, 2023, pp.104172. ⟨10.1016/j.drugpo.2023.104172⟩
Article dans une revue hal-04794897 v1

Efficacy and Safety of Electroconvulsive Therapy in Patients With Deep Brain Stimulation

Nicolas Bukowski , Andrew Laurin , Edouard Laforgue , Cécile Preterre , Tiphaine Rouaud et al.
Journal of ECT, 2022, 38 (3), pp.e29-e40. ⟨10.1097/YCT.0000000000000828⟩
Article dans une revue hal-04783913 v1
Image document

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Marion Istvan , Benoit Schreck , Marie Mainguy , Pascale Jolliet , Marie Grall-Bronnec et al.
Journal of Clinical Medicine, 2022, 11 (8), pp.2176. ⟨10.3390/jcm11082176⟩
Article dans une revue hal-03678956 v1
Image document

Evolution of sexual functioning of men through treated and untreated depression

É-J Laforgue , G. Busnel , D. Lauzeille , M. Bronnec , Clémence Cabelguen et al.
Article dans une revue hal-03406872 v1
Image document

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study

Morgane Guillou Landreat , Antoine Dany , Gaëlle Challet-Bouju , Edouard-Jules Laforgue , Jennifer Cholet et al.
Harm Reduction Journal, 2022, 19 (1), pp.31. ⟨10.1186/s12954-022-00608-6⟩
Article dans une revue hal-03629554 v1
Image document

Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users

Edouard-Jules Laforgue , Morgane Rousselet , Antoine Claudon , Aurélie Aquizerate , Pascale Jolliet et al.
International Journal of Environmental Research and Public Health, 2022, 19 (15), pp.8920. ⟨10.3390/ijerph19158920⟩
Article dans une revue hal-04764984 v1

Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database

Marion Istvan , Morgane Rousselet , Edouard-Jules Laforgue , Marylène Guerlais , Marie Gérardin et al.
Expert Opinion on Drug Safety, 2022, 21 (9), pp.1225-1234. ⟨10.1080/14740338.2022.2047930⟩
Article dans une revue hal-04796549 v1

ZORRO: When the mask falls off—Comment

Marion Istvan , Edouard-Jules Laforgue , Marylène Guerlais , Pascale Jolliet , Caroline Victorri-Vigneau
British Journal of Clinical Pharmacology, 2021, ⟨10.1111/bcp.15086⟩
Article dans une revue hal-03406898 v1

CYP1A2 and tobacco interaction

Malcolm Barrangou-Poueys-Darlas , Marylène Guerlais , Edouard-Jules Laforgue , Ronan Bellouard , Marion Istvan et al.
Drug Metabolism Reviews, 2021, 53 (1), pp.30-44. ⟨10.1080/03602532.2020.1859528⟩
Article dans une revue hal-03407082 v1

What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database

Edouard-Jules Laforgue , Marion Istvan , Marylène Guerlais , Anicet Chaslerie , Pascal Artarit et al.
Expert Opinion on Drug Safety, 2021, 20 (10), pp.1247-1256. ⟨10.1080/14740338.2021.1939304⟩
Article dans une revue hal-03406940 v1
Image document

Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People?

Alexandra Jobert , Marion Istvan , Edouard-Jules Laforgue , Benoit Schreck , Caroline Victorri-Vigneau
International Journal of Environmental Research and Public Health, 2021, 18, ⟨10.3390/ijerph182212099⟩
Article dans une revue hal-03445931 v1

Slam Practice :

Benoit Schreck , Caroline Victorri-Vigneau , Marylène Guerlais , Edouard-Jules Laforgue , Marie Grall-Bronnec
European Addiction Research, 2021, 27 (3), pp.161-178. ⟨10.1159/000511897⟩
Article dans une revue hal-04994156 v1

Change in the regulatory framework for zolpidem

Marion Istvan , Pascal Caillet , Morgane Rousselet , Marylène Guerlais , Edouard-Jules Laforgue et al.
British Journal of Clinical Pharmacology, 2021, 87 (8), pp.3310-3319. ⟨10.1111/bcp.14753⟩
Article dans une revue hal-03407064 v1

Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?

Alexandra Jobert , Edouard Laforgue , Marie Grall-Bronnec , Morgane Rousselet , Morgane Péré et al.
European Journal of Clinical Pharmacology, 2021, 77 (2), pp.171-177. ⟨10.1007/s00228-020-03007-7⟩
Article dans une revue hal-03244134 v1
Image document

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report

Morgane Guillou-Landréat , Antoine Dany , Gaëlle Challet-Bouju , Edouard Laforgue , Juliette Leboucher et al.
International Journal of Environmental Research and Public Health, 2021, 18 (4), pp.1425. ⟨10.3390/ijerph18041425⟩
Article dans une revue hal-03211107 v1

Are Seniors Dependent on Benzodiazepines?

Caroline Victorri-Vigneau , Edouard-Jules Laforgue , Marie Grall-Bronnec , Morgane Guillou-Landreat , Morgane Rousselet et al.
Clinical Pharmacology and Therapeutics, 2021, 109 (2), pp.528-535. ⟨10.1002/cpt.2025⟩
Article dans une revue hal-03407111 v1

Cannabinoid Hyperemesis Syndrome Among Pregnant Women

Edouard-Jules Laforgue , Aurore Lesage , Benoit Schreck , Marylène Guerlais , Caroline Victorri-Vigneau
Journal of Studies on Alcohol and Drugs, 2020, 81 (6), pp.824-825
Article dans une revue hal-03407086 v1
Image document

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness

Audrey Verholleman , Caroline Victorri-Vigneau , Edouard Laforgue , Pascal Derkinderen , Celine Verstuyft et al.
International Journal of Molecular Sciences, 2020, 21 (8), pp.3002. ⟨10.3390/ijms21083002⟩
Article dans une revue hal-03159491 v1
Image document

Cathinone Use Disorder in the Context of Slam Practice

Benoit Schreck , Marylène Guerlais , Edouard Laforgue , Célia Bichon , Marie Grall-Bronnec et al.
Frontiers in Psychiatry, 2020, 11, ⟨10.3389/fpsyt.2020.00705⟩
Article dans une revue hal-04063101 v1
Image document

Do Older People Know Why They Take Benzodiazepines? A National French Cross-Sectional Survey of Long-Term Consumers

Edouard‐jules Laforgue , Alexandra Jobert , Morgane Rousselet , Marie Grall-Bronnec , Pascale Jolliet et al.
International Journal of Geriatric Psychiatry, 2020, 35 (8), pp.870-876. ⟨10.1002/gps.5307⟩
Article dans une revue hal-03159473 v1
Image document

Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study

Marie Grall-Bronnec , Edouard Laforgue , Gaëlle Challet-Bouju , Jennyfer Cholet , Jean-Benoit Hardouin et al.
Frontiers in Psychiatry, 2019, 10, pp.726. ⟨10.3389/fpsyt.2019.00726⟩
Article dans une revue hal-03158795 v1

Relevance of CYP2B6 and CYP2D6 Genotypes to Methadone Pharmacokinetics and Response in the OPAL Study

Caroline Victorri-Vigneau , Céline Verstuyft , Régis Bouquié , Edouard Laforgue , Jean-Benoit Hardouin et al.
British Journal of Clinical Pharmacology, 2019, 85 (7), pp.1538-1543. ⟨10.1111/bcp.13936⟩
Article dans une revue hal-03158829 v1

Management of Emergency Electroconvulsive Therapy in the Intensive Care Unit for Life-Threatening Psychiatric Conditions: A Case Series

Samuel Bulteau , Edouard Laforgue , Loïc Chimot , Romain Dumont , Olivier Loutrel et al.
The journal of ECT, 2018, 34 (1), pp.55-59. ⟨10.1097/YCT.0000000000000451⟩
Article dans une revue hal-03158600 v1

Bipolar Disorder and Adherence: Implications of Manic Subjective Experience on Treatment Disruption

Samuel Bulteau , Marie Grall-Bronnec , Pierre-Yves Bars , Edouard Laforgue , François Etcheverrigaray et al.
Patient Preference and Adherence, 2018, 12, pp.1355-1361. ⟨10.2147/PPA.S151838⟩
Article dans une revue hal-03158599 v1

Dynamics of Postural Control during Repetitive Transcranial Magnetic Stimulation in an Adult with Major Depressive Disorder

Thibault Deschamps , Anne Sauvaget , Edouard Laforgue , Samuel Bulteau , Véronique Thomas-Ollivier
The Australian and New Zealand Journal of Psychiatry, 2018, 52 (3), pp.291-293. ⟨10.1177/0004867417742520⟩
Article dans une revue hal-03158607 v1

Efficacy of Intermittent Theta Burst Stimulation (iTBS) and 10-Hz High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment-Resistant Unipolar Depression: Study Protocol for a Randomised Controlled Trial

Samuel Bulteau , Véronique Sébille , Guillemette Fayet , Veronique Thomas-Ollivier , Thibault Deschamps et al.
Trials, 2017, 18 (1), pp.17. ⟨10.1186/s13063-016-1764-8⟩
Article dans une revue hal-03158125 v1